Alzheimer’s Prevention

Pre-Alzheimer’s for Healthy Adults

The Alzheimer’s Prevention Study is for people with a specific genetic marker related to early onset Alzheimer’s Disease. To qualify, you need to meet the following requirements:

  • 60 to 75 years of age in overall good health
  • No current form of dementia or other cognitive impairment
  • 1 or 2 copies of the APOE e4 gene (genetic testing and counseling are included)
  • Study partner such as a spouse or close friend willing to attend study visits
Learn More and Register

Arthritis

Arthritis of the Knee – Mild Pain

This study is for healthy participants between the ages of 40 and 85 with a clinical diagnosis of osteoarthritis (OA) of the Knee. To qualify, you need to meet the following requirements:

  • Symptoms for more than 6 months and use of an NSAID (ibuprofen, aspirin, naproxen) at least 3x per week for pain control
  • Mild overall pain level between 2 – 4 on a scale of 0 – 10 in the most painful knee, occasional higher levels of pain are common and are allowed in the study.
  • No major surgery on knee in the past
  • Not currently on opioids for any pain control
  • Negative drug / alcohol test (performed at first visit)
Learn More and Register

Gout

Gout with Recent Flare

This study is for people with gout. To qualify, you need to meet the following requirements:

  • Ages 21 – 75, if female must not be of childbearing potential
  • Have blood uric acid of 6mg/dL or higher (tested at screening visit)
  • At least one gout flare in the last six months
Learn More and Register

Heart Failure

Congestive Heart Failure

This study is for men and women 60+ who have a clinical diagnosis of heart failure. To qualify, you need to meet the following requirements

  • Diagnosis of heart failure from your doctor
  • Heart pumping efficiency (ejection fraction) of 40% or greater (can be measured at screening)
  • Have not used Entresto in the past
  • No acute coronary events in the last 90 days
  • Not currently diagnosed with Alzheimer’s Disease
Learn More and Register

Diabetes

Type 2 Diabetes and Weight Loss

Type 2 Diabetes and Weight Loss is a 30-week clinical trial of a treatment for Type II diabetes that may help improve glycemic control and promote weight loss. There are up to 18 clinic visits the study and you are paid $50 your time and travel at each visit. Qualifications include:

  • Diagnosis of Type 2 diabetes, controlled with a stable dose of metformin or by diet and exercise alone
  • Limited use of insulin the last year
  • HbA1c level between 7% and 10.5%
  • Willing to self-administer weekly injection and follow lifestyle advice
  • No significant weight change in the last 3 months
  • This study is not for people currently on insulin
Learn More and Register
Delayed Stomach Emptying (Gastroparesis)

Delayed Stomach Emptying (Gastroparesis)

This is a clinical trial for patients with diabetes who suffer from delayed digestion sometimes called gastroparesis. To qualify, you need to meet the following requirements:

  • Type 1 or type 2 diabetes diagnosed at least 5 years ago
  • HbA1c of 11 or below (tested at screening)
  • BMI between 18 and 36
  • At least 3 months of symptoms including: vomiting, nausea, early full feeling when eating, extended full feeling after eating, bloating or pain
  • Recent vomiting episodes
Learn More and Register

Diabetes and Fatty Liver (NASH)

NASH is usually associated with diabetes and high blood lipids. To qualify, you need to meet the following requirements

  • Type 2 diabetes
  • Blood lipid (triglycerides) level of 200 md/dL or higher (tested at screening)
  • Not on insulin
  • High level of liver fat (tested at screening)
Learn More and Register

High Triglycerides and Diabetes

The High Triglycerides and Diabetes Study is for people with high triglycerides and type 2 diabetes. To qualify, you need to meet the following requirements

  • Blood lipid (triglycerides) level of 200 md/dL or higher (tested at screening)
  • Type 2 Diabetes
  • Good cholesterol control
  • Male age 50 and older, female age 55 and older
  • Or age 18 and older and have a history of heart problems
  • On a stable moderate-to-high dose of a statin or statin intolerant
Learn More and Register

Future Studies

Upcoming Studies for Men & Women

If would like to be contacted for future study opportunities, click to apply here.

Learn More and Register